Alzheimer’s disease

Alzheimer’s disease is the most frequent cause of dementia and one of the most

Learn more

NanoSIRNA

NanosiRNA® COVID-19: specific antiviral treatment Medesis Pharma has a microemulsion

Learn more

NanoManganese

Medesis Pharma is developing a radioprotection drug to treat people irradiated following

Learn more

Viral diseases

Medesis Pharma is developing a radioprotection drug to treat people irradiated following

Learn more

Nuclear radioprotection drug

The objective of the radioprotection program is to develop a radiomitigation drug,

Learn more

Cesium decorporation

NU02 Cesium decorporation 137Cs is gamma and beta emitting by-product of uranium

Learn more

AONYS® drug delivery technology

AONYS® is a mix of lipidic components that spontaneously assemble into a water-in-oil

Learn more

Drug to treat neurodegenerative diseases

NanoLithium® (NP03) is a disease-modifying nano dose formulation of lithium citrate

Learn more

Treatment of Huntington’s disease

Huntington’s disease (HD) is a dominantly inherited neurodegenerative disease due

Learn more

Nuclear decorporation drugs – Plutonium decorporation

NU01 Plutonium decorporation Plutonium (Pu) is an alpha emitting radionuclide which

Learn more